Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box

被引：18
|
作者：
Vanfleteren, Lowie E. G. W. [1 ]
Ullman, Anders [1 ]
Nordenson, Anita [1 ]
Andersson, Anders [1 ]
Andelid, Kristina [1 ]
Fabbri, Leonardo M. [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, COPD Ctr, Gothenburg, Sweden
来源：
ERJ OPEN RESEARCH | 2019年 / 5卷 / 01期
关键词：
OBSTRUCTIVE PULMONARY-DISEASE; DOUBLE-BLIND; FLUTICASONE FUROATE; INHALED BUDESONIDE; PARALLEL-GROUP; EXACERBATIONS; VILANTEROL; MODERATE; RISK; GLUCOCORTICOIDS;
D O I：
10.1183/23120541.00185-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD Cohort Study in Real-World Clinical Practice
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    [J]. CHEST, 2020, 157 (04) : 846 - 855
  • [42] Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis
    Rogliani, P.
    Cazzola, M.
    Verri, S.
    Camardelli, F.
    Calzetta, L.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Koarai, Akira
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [44] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Akira Koarai
    Mitsuhiro Yamada
    Tomohiro Ichikawa
    Naoya Fujino
    Tomotaka Kawayama
    Hisatoshi Sugiura
    [J]. Respiratory Research, 22
  • [45] Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study
    Canonica, G. W.
    Virchow, J.
    Kots, M.
    Zuccaro, F.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [46] Evaluation of Time-to-Triple Therapy in Patients Diagnosed with COPD Initiating Maintenance Therapy with a Fixed-Dose Combination of LAMA/LABA Versus ICS/LABA Within a Large US Health Insurer Database
    Moretz, C.
    Bengtson, L. G. S.
    Sharpsten, L.
    Le, L.
    Koep, E.
    Tong, J.
    Hahn, B.
    Stanford, R. H.
    Asmus, M. J.
    Ray, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [47] Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
    Rothnie, Kieran J.
    Quint, Jennifer K.
    [J]. CHEST, 2020, 158 (02) : 831 - 832
  • [48] Switch from LABA plus ICS to a LABA/LAMA combination in symptomatic women with COPD - an analysis of the observational DACCORD study
    Kardos, Peter
    Buhl, Roland
    Criee, Carl-Peter
    Lossi, Nadine
    Vogelmeier, Claus
    Worth, Heinrich
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [49] Single Inhaler LABA/LAMA for COPD
    Malerba, Mario
    Foci, Valentina
    Patrucco, Filippo
    Pochetti, Patrizia
    Nardin, Matteo
    Pelaia, Corrado
    Radaeli, Alessandro
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [50] Assessing the Escalation Time to Open Triple Therapy from Initiation of LAMA vs ICS/LABA in COPD Management; Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS Study)
    Kim, Y.
    Rhee, C.
    Hwang, Y.
    Yoo, K.
    Lee, S.
    Park, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345